A new wireless and wearable device developed by Northwestern Medicine scientists, in collaboration with Northwestern University spinout company, Epicore Biosystems, measures specific biomarkers in a person’s sweat with similar accuracy to standard testing methods and has the potential to improve clinical decision-making for cystic fibrosis, as detailed in a recent study published in the Proceedings of the National Academy of Sciences.
This article was originally published on MedicalXpress.com
Do you want to know more about attachment types and adult relationships? If so, you’ve come to the right place! In this blog, we’ll examine how different attachment styles impact our relationships and how understanding […]
Chronic wasting disease (CWD), a devastating prion illness that affects North American cervids like deer and elk, poses a grave threat to their well-being and conservation efforts. Furthermore, it presents a potential risk of human […]
Microneedling is a revolutionary skincare treatment that has gained popularity in recent years due to its numerous benefits, including reducing the appearance of scars, wrinkles, and acne, and promoting collagen production. Edmonton, the bustling capital […]
© 2025 SimplyWell.ca